These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 27321574)

  • 1. New milestones ahead in complement-targeted therapy.
    Ricklin D; Lambris JD
    Semin Immunol; 2016 Jun; 28(3):208-22. PubMed ID: 27321574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic control of complement activation at the level of the central component C3.
    Ricklin D; Lambris JD
    Immunobiology; 2016 Jun; 221(6):740-6. PubMed ID: 26101137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renaissance of complement therapeutics.
    Ricklin D; Mastellos DC; Reis ES; Lambris JD
    Nat Rev Nephrol; 2018 Jan; 14(1):26-47. PubMed ID: 29199277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.
    Mastellos DC; Reis ES; Yancopoulou D; Hajishengallis G; Ricklin D; Lambris JD
    Immunobiology; 2016 Oct; 221(10):1046-57. PubMed ID: 27353192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.
    Ricklin D
    Immunobiology; 2012 Nov; 217(11):1057-66. PubMed ID: 22964231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tipping the balance: intricate roles of the complement system in disease and therapy.
    Pouw RB; Ricklin D
    Semin Immunopathol; 2021 Dec; 43(6):757-771. PubMed ID: 34698894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-targeted therapeutics.
    Ricklin D; Lambris JD
    Nat Biotechnol; 2007 Nov; 25(11):1265-75. PubMed ID: 17989689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding horizons in complement drug discovery: challenges and emerging strategies.
    Harris CL
    Semin Immunopathol; 2018 Jan; 40(1):125-140. PubMed ID: 28986638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical promise of next-generation complement therapeutics.
    Mastellos DC; Ricklin D; Lambris JD
    Nat Rev Drug Discov; 2019 Sep; 18(9):707-729. PubMed ID: 31324874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement in clinical medicine: Clinical trials, case reports and therapy monitoring.
    Ricklin D; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():10-21. PubMed ID: 28576323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement, a target for therapy in inflammatory and degenerative diseases.
    Morgan BP; Harris CL
    Nat Rev Drug Discov; 2015 Dec; 14(12):857-77. PubMed ID: 26493766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery.
    Mastellos DC; Reis ES; Ricklin D; Smith RJ; Lambris JD
    Trends Immunol; 2017 Jun; 38(6):383-394. PubMed ID: 28416449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and autoimmunity.
    Ballanti E; Perricone C; Greco E; Ballanti M; Di Muzio G; Chimenti MS; Perricone R
    Immunol Res; 2013 Jul; 56(2-3):477-91. PubMed ID: 23615835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-targeted therapeutics: An emerging field enabled by academic drug discovery.
    Lamers C; Ricklin D; Lambris JD
    Am J Hematol; 2023 May; 98 Suppl 4():S82-S89. PubMed ID: 36755352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Activation in Inflammatory Skin Diseases.
    Giang J; Seelen MAJ; van Doorn MBA; Rissmann R; Prens EP; Damman J
    Front Immunol; 2018; 9():639. PubMed ID: 29713318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads.
    Tatapudi VS; Montgomery RA
    Front Immunol; 2019; 10():2306. PubMed ID: 31632397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Therapeutic Modulation of the Complement System: Clinical Indications and Emerging Drug Leads.
    Mastellos DC; Reis ES; Lambris JD
    Front Immunol; 2019; 10():3029. PubMed ID: 31998311
    [No Abstract]   [Full Text] [Related]  

  • 18. Developments in anti-complement therapy; from disease to clinical trial.
    Harris CL; Pouw RB; Kavanagh D; Sun R; Ricklin D
    Mol Immunol; 2018 Oct; 102():89-119. PubMed ID: 30121124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.
    Mastellos DC; Ricklin D; Hajishengallis E; Hajishengallis G; Lambris JD
    Mol Oral Microbiol; 2016 Feb; 31(1):3-17. PubMed ID: 26332138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.